Insulin glargin v lechenii sakharnogo diabeta 2 tipa: dokazatel'naya otsenka ego klinicheskoy i ekonomicheskoy effektivnosti

Insulin glargin v lechenii sakharnogo diabeta 2 tipa: dokazatel'naya otsenka ego klinicheskoy i ekonomicheskoy effektivnosti

СД2 является хроническим заболеванием, ведущим к преждевременной инвалидизации и смертности вследствие развития микрососудистых и макрососудистых осложнений. Лечение СД2 и его осложнений, а также экономические потери вследствие нетрудоспособности и смертности лиц трудоспособного возраста ложатся тяж...

Full description

Bibliographic Details
Main Author:	Irina Vladimirovna Glinkina
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2008-12-01
Series:	Сахарный диабет
Subjects:	инсулин гларгин лантус сахарный диабет 2 типа
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6510

Similar Items

Otsenka klinicheskogo primeneniya Lantusa (insulina glargin) v praktike raboty endokrinologicheskoy sluzhby Moskvy
by: Mikhail Borisovich Antsiferov, et al.
Published: (2005-06-01)

Lantus (Insulin Glargin): new insulin on Russian market
by: Editorial team Diabetes Mellitus
Published: (2003-03-01)

Opyt primeneniya Lantusa (glargin) u detey i podrostkov s sakharnym diabetom 1 tipa v klinicheskoy praktike
by: E E Petryaykina, et al.
Published: (2006-03-01)

Lantus (insulin glargin): real'nye preimushchestva i perspektivy primeneniya v pediatrii
by: Valentina Alexandrovna Peterkova, et al.
Published: (2003-09-01)

Issledovanie effektivnosti i bezopasnosti primeneniya pervogo bespikovogo analoga chelovecheskogo insulina dlitel'nogo deystviya lantus (glargin) u detey i podrostkov
by: Valentina Alexandrovna Peterkova, et al.
Published: (2004-09-01)

The pharmacoeconomic comparison of the fixed insulin glargine and lixisenatide combination with insulin degludec family in type 2 diabetes mellitus
by: I. N. Dyakov, et al.
Published: (2021-02-01)

Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
by: I. N. Dyakov, et al.
Published: (2020-09-01)

Development and Validation of Approach for the Detection of Neutralizing Antibodies Against Insulin (Glargine) in Human Blood Plasma
by: N. B. Abramenko, et al.
Published: (2019-09-01)

Perindopril: dokazatel'naya bazai vozmozhnosti primeneniya
by: D A Napalkov, et al.
Published: (2011-06-01)

Dokazatel'naya baza primeneniya amlodipina pri lechenii arterial'noy gipertenzii
by: S V Nedogoda, et al.
Published: (2008-06-01)

COMPARATIVE STUDY OF INTERACTION OF SOME DOMESTIC HUMAN INSULIN SUBSTANCES AND ITS ANALOGUES WITH INSULIN RECEPTOR BY METHOD OF SURFACE PLASMON RESONANCE
by: I. N. Urakova, et al.
Published: (2019-01-01)

Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2
by: S. V. Nedogoda, et al.
Published: (2020-01-01)

Sravnenie kombinatsiy insulina lizpromiks 25 s metforminom i insulina glarginas metforminom pri lechenii patsientovs sakharnym diabetom 2 tipa,ranee ne poluchavshikh insulinoterapii(16-nedel'noe randomizirovannoe otkrytoeperekrestnoe issledovanie)
by: J K Malone, et al.
Published: (2006-06-01)

Фармакоэкономическое сравнение базальных аналогов инсулина при сахарном диабете 2 типа
Published: (2018-06-01)

Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base
by: I. N. Dyakov, et al.
Published: (2021-04-01)

Health technology assessement of the fxed combination of insulin glargine 100 UI/ml and lixisenatide in the treatment intensifcation of diabetes mellitus type 2
by: S. К. Zyryanov, et al.
Published: (2019-01-01)

Basal insulin analogues in the diabetes mellitus type 2 control — economic aspects
by: D. Yu. Belousov, et al.
Published: (2018-06-01)

Novye vozmozhnosti insulinoterapii sakharnogo diabeta u detey i podrostkov
by: Tamara Leonidovna Kuraeva, et al.
Published: (2007-03-01)

The clinical-economic characteristic of current basis-bolus insulin therapy schemes in diabetes mellitus type 1 in adults
by: A. S. Kolbin, et al.
Published: (2022-05-01)

Kriterii diagnoza sakharnogo diabeta i prognoz glyukoznoy intolerantnosti
by: Leonid Grigor'evich Strongin
Published: (2002-03-01)

Mozhno li dostignut' effektivnogo glikemicheskogo kontrolya sakharnogo diabeta 2 tipa: preimushchestva rannego naznacheniya insulina
by: Elena Valer'evna Biryukova
Published: (2008-03-01)

Apidra (insulin glulizin) v terapii sakharnogo diabeta 1 tipa
by: M G Pavlova
Published: (2008-06-01)

Osnovnye printsipy terapii sakharnogo diabeta 2 tipa
by: Ivan Ivanovich Dedov, et al.
Published: (1999-03-01)

Geneticheskie markery i funktsiya (beta-kletok v rannikh (doklinicheskikh) stadiyakh sakharnogo diabeta tipa 1
by: Tamara Leonidovna Kuraeva, et al.
Published: (2002-06-01)

Dvukhfaznyy insulin aspart 30 plyusmetformin: effektivnaya kombinatsiyadlya lecheniya sakharnogo diabeta 2 tipa
by: M Kvapil, et al.
Published: (2006-06-01)

Economic aspects of second generation insulin analogs in diabetes mellitus type 2
by: Dmitry Yurievich Belousov, et al.
Published: (2019-08-01)

Клинико-экономическое сравнение инсулина гларгин и инсулина премикс аспарт при сахарном диабете типа 2
Published: (2018-07-01)

151. SRAVNITEL'NAYa OTsENKA KLINIChESKOY EFFEKTIVNOSTI KSEFOKAMA I DIKLOFENAKA U BOL'NYKh REVMATOIDNYM ARTRITOM
by: L K Peshekhonova, et al.
Published: (2000-08-01)

The economic prognosis of the new analog of insulin glargine usage in diabetes mellitus type 2
by: D. Yu. Belousov, et al.
Published: (2018-05-01)

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pharmacoeconomic characteristics of agonists of receptors for glucagon-like peptide-1 and medicines on their base
by: I. N. Dyakov, et al.
Published: (2021-08-01)

Economic evaluation of insulin therapy intensification for effective and safe control of diabetes mellitus type 2
by: A. S. Kolbin, et al.
Published: (2019-10-01)

Клинико-экономический анализ базальных аналогов инсулина при сахарном диабете 2 типа в условиях реальной практики
Published: (2018-06-01)

Poslednie dostizheniya i perspektivy profilaktiki sakharnogo diabeta 1 tipa
by: Tamara Leonidovna Kuraeva, et al.
Published: (2000-03-01)

The economic side of an oral sugar lowering therapy intensification by glucagon-like peptidt-1 receptor agonists
by: S. K. Zyryanov, et al.
Published: (2022-02-01)

Erektil'naya disfunktsiya kak odno iz proyavleniy dekompensatsii sakharnogo diabeta
by: D I Esaulenko, et al.
Published: (2005-03-01)

Antioksidanty v lechenii i profilaktike sakharnogo diabeta
by: Irina Arkad'evna Bondar', et al.
Published: (2001-03-01)

O lechenii sakharnogo diabeta 2 tipa glimepiridom
by: Ashot Musaelovich Mkrtumyan
Published: (2000-12-01)

Vozmozhnosti kletochnykh tekhnologiy v lechenii sakharnogo diabeta
by: Tatiana Vasil'evna Nikonova, et al.
Published: (2008-12-01)

Glibomet v lechenii sakharnogo diabeta 2 tipa
by: Alexander Sergeevich Ametov, et al.
Published: (2007-06-01)